4AB:ETR
AbbVie Common Stock
258,70 €
arrow_upward
+0,82%(+2,10) 1D
20-ноя., 09:16:11 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
260,90 €
High
260,90 €
Low
258,70 €
Mkt. cap
501,19 млд
Avg. vol.
651,00
Volume
82,00
52-wk high
272,20 €
52-wk low
162,85 €
No. of employees
57 миң
Open
260,90 €
High
260,90 €
Low
258,70 €
Mkt. cap
501,19 млд
Avg. vol.
651,00
Volume
82,00
52-wk high
272,20 €
52-wk low
162,85 €
No. of employees
57 миң
News stories
From web sources and news partners
Euronext Markets: Real-time Stock Market Data | live
·
17 саат мурун
AbbVie expands bispecific cancer med push with up to $2.5 billion deal with Germany's Disco
ad-hoc-news.de
·
18 саат мурун
AbbVie stock: Piper Sandler raises target to USD 349
Pharmaceutical Executive
·
18 саат мурун
DISCO, AbbVie Sign AND-Gated Bispecific Deal Worth Up to $2.5B
Puerto Rico Federal Affairs Administration (.gov)
·
2 күн мурун
NEW of PRFAA
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 миң
Founded2012-ж., 10-апр.
HeadquartersСевер Чикаго, Иллинойс, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Websiteabbvie.com